Terumo (STU:TUO) Other Current Liabilities: €654 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TUO Terumo Corp STU:TUO
82 GF Score
Price €14.26
GF Value €16.88
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Terumo Other Current Liabilities?

Terumo STU:TUO +0.46% 82 Other Current Liabilities is €654 Mil as of Jun. 2026. GuruFocus rates STU:TUO with a GF Score™ of 82/100 and a GF Value™ of €16.88 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Terumo's other current liabilities for the quarter that ended in Jun. 2026 was €654 Mil.

Terumo's quarterly other current liabilities increased from Dec. 2025 (€657 Mil) to Mar. 2026 (€732 Mil) but then declined from Mar. 2026 (€732 Mil) to Jun. 2026 (€654 Mil).

Terumo's annual other current liabilities increased from Mar. 2024 (€627 Mil) to Mar. 2025 (€689 Mil) and increased from Mar. 2025 (€689 Mil) to Mar. 2026 (€732 Mil).

Terumo Other Current Liabilities Related Terms

Terumo Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Terumo's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Other Current Liabilities Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 619.88 597.30 626.63 689.45 731.86

Terumo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 596.04 613.97 657.06 731.86 653.83
STU:TUO
82GF Score
Terumo Corp STU:TUO
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Terumo Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €654 Mil mean?
Terumo (STU:TUO) has a Other Current Liabilities of €654 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Terumo.
Is Terumo's Other Current Liabilities too high?
Terumo's current Other Current Liabilities is €654 Mil. Overall, Terumo has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Other Current Liabilities compare to ISRG and BDX?
Terumo's Other Current Liabilities of €654 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Terumo. Terumo's current Other Current Liabilities is €654 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (STU:TUO) is currently considered Modestly Undervalued. The stock's GF Value™ is €16.88, compared to a current price of €14.26 — trading 15.6% below its estimated fair value. The current Other Current Liabilities is €654 Mil. Terumo's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Terumo (STU:TUO), the current Other Current Liabilities is €654 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (STU:TUO) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of €14.26 is trading 15.6% below its estimated GF Value™ of €16.88. GuruFocus considers Terumo to be Modestly Undervalued.

Key valuation signals for STU:TUO:

  • Other Current Liabilities: €654 Mil
  • GF Value™: €16.88 vs. price of €14.26 (15.6% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the STU:TUO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
82GF Score

Get the complete analysis for STU:TUO

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.26
Price
€16.88
GF Value